• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解测量时间对药物特性描述的影响。

Understanding the effect of measurement time on drug characterization.

机构信息

Department of Physics & Astronomy, Texas Christian University, Fort Worth, TX, United States of America.

出版信息

PLoS One. 2020 May 14;15(5):e0233031. doi: 10.1371/journal.pone.0233031. eCollection 2020.

DOI:10.1371/journal.pone.0233031
PMID:32407356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7224495/
Abstract

In order to determine correct dosage of chemotherapy drugs, the effect of the drug must be properly quantified. There are two important values that characterize the effect of the drug: εmax is the maximum possible effect of a drug, and IC50 is the drug concentration where the effect diminishes by half. There is currently a problem with the way these values are measured because they are time-dependent measurements. We use mathematical models to determine how the εmax and IC50 values depend on measurement time and model choice. Seven ordinary differential equation models (ODE) are used for the mathematical analysis; the exponential, Mendelsohn, logistic, linear, surface, Bertalanffy, and Gompertz models. We use the models to simulate tumor growth in the presence and absence of treatment with a known IC50 and εmax. Using traditional methods, we then calculate the IC50 and εmax values over fifty days to show the time-dependence of these values for all seven mathematical models. The general trend found is that the measured IC50 value decreases and the measured εmax increases with increasing measurement day for most mathematical models. Unfortunately, the measured values of IC50 and εmax rarely matched the values used to generate the data. Our results show that there is no optimal measurement time since models predict that IC50 estimates become more accurate at later measurement times while εmax is more accurate at early measurement times.

摘要

为了确定化疗药物的正确剂量,必须对药物的效果进行适当的量化。有两个重要的值可以描述药物的效果:εmax 是药物的最大可能效果,IC50 是药物效果减半的浓度。目前,这些值的测量方法存在问题,因为它们是时间相关的测量。我们使用数学模型来确定 εmax 和 IC50 值如何随测量时间和模型选择而变化。我们使用了七种常微分方程模型(ODE)进行数学分析;指数模型、门德尔松模型、逻辑斯谛模型、线性模型、曲面模型、贝塔朗菲模型和戈梅茨模型。我们使用这些模型模拟了存在和不存在已知 IC50 和 εmax 的情况下肿瘤的生长。然后,我们使用传统方法在五十天内计算了这些值的 IC50 和 εmax 值,以展示所有七种数学模型中这些值的时间依赖性。一般趋势是,对于大多数数学模型,测量的 IC50 值随着测量天数的增加而降低,而测量的 εmax 值随着测量天数的增加而增加。不幸的是,IC50 和 εmax 的测量值很少与生成数据时使用的值匹配。我们的结果表明,由于模型预测 IC50 估计在后期测量时间会变得更准确,而 εmax 在早期测量时间会更准确,因此没有最佳的测量时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58d/7224495/a8b0d62a7847/pone.0233031.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58d/7224495/9d72d1fe44e1/pone.0233031.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58d/7224495/1d4165bb0b14/pone.0233031.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58d/7224495/c6219f72c7d1/pone.0233031.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58d/7224495/e8420f2ea997/pone.0233031.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58d/7224495/a8b0d62a7847/pone.0233031.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58d/7224495/9d72d1fe44e1/pone.0233031.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58d/7224495/1d4165bb0b14/pone.0233031.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58d/7224495/c6219f72c7d1/pone.0233031.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58d/7224495/e8420f2ea997/pone.0233031.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e58d/7224495/a8b0d62a7847/pone.0233031.g005.jpg

相似文献

1
Understanding the effect of measurement time on drug characterization.了解测量时间对药物特性描述的影响。
PLoS One. 2020 May 14;15(5):e0233031. doi: 10.1371/journal.pone.0233031. eCollection 2020.
2
Differences in predictions of ODE models of tumor growth: a cautionary example.肿瘤生长常微分方程模型预测的差异:一个警示性例子。
BMC Cancer. 2016 Feb 26;16:163. doi: 10.1186/s12885-016-2164-x.
3
On the MTD paradigm and optimal control for multi-drug cancer chemotherapy.多药癌症化疗的 MTD 范式与最优控制
Math Biosci Eng. 2013 Jun;10(3):803-19. doi: 10.3934/mbe.2013.10.803.
4
Comparison of Drug Inhibitory Effects ([Formula: see text]) in Monolayer and Spheroid Cultures.单层培养和球体培养中的药物抑制效果比较([公式:见正文])。
Bull Math Biol. 2020 Jun 3;82(6):68. doi: 10.1007/s11538-020-00746-7.
5
Gompertz model with delays and treatment: mathematical analysis.带时滞和治疗的 Gompertz 模型:数学分析。
Math Biosci Eng. 2013 Jun;10(3):551-63. doi: 10.3934/mbe.2013.10.551.
6
Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.癌症化疗中具有药代动力学的模型的最优控制,用于使骨髓最大化
Math Biosci. 2007 Apr;206(2):320-42. doi: 10.1016/j.mbs.2005.03.013. Epub 2005 Sep 28.
7
Classical mathematical models for prediction of response to chemotherapy and immunotherapy.用于预测化疗和免疫治疗反应的经典数学模型。
PLoS Comput Biol. 2022 Feb 4;18(2):e1009822. doi: 10.1371/journal.pcbi.1009822. eCollection 2022 Feb.
8
Mathematical modelling of liposomal drug release to tumour.脂质体药物向肿瘤的释放的数学建模。
Math Biosci. 2018 Dec;306:82-96. doi: 10.1016/j.mbs.2018.10.012. Epub 2018 Nov 1.
9
Mathematical Based Calculation of Drug Penetration Depth in Solid Tumors.基于数学方法计算实体肿瘤中的药物渗透深度。
Biomed Res Int. 2016;2016:8437247. doi: 10.1155/2016/8437247. Epub 2016 Jun 8.
10
Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy.肿瘤抗血管生成联合化疗的数学模型的最优和次优方案。
Math Biosci Eng. 2011 Apr;8(2):307-23. doi: 10.3934/mbe.2011.8.307.

引用本文的文献

1
Assessment of Cell Viability in Drug Therapy: IC50 and Other New Time-Independent Indices for Evaluating Chemotherapy Efficacy.药物治疗中细胞活力的评估:IC50及其他评估化疗疗效的新的与时间无关的指标
Pharmaceutics. 2025 Feb 13;17(2):247. doi: 10.3390/pharmaceutics17020247.
2
Estimation of virus-mediated cell fusion rate of SARS-CoV-2.估算 SARS-CoV-2 介导的病毒细胞融合率。
Virology. 2022 Oct;575:91-100. doi: 10.1016/j.virol.2022.08.016. Epub 2022 Sep 7.
3
Using mathematical modeling to estimate time-independent cancer chemotherapy efficacy parameters.

本文引用的文献

1
Biphasic Mathematical Model of Cell-Drug Interaction That Separates Target-Specific and Off-Target Inhibition and Suggests Potent Targeted Drug Combinations for Multi-Driver Colorectal Cancer Cells.细胞-药物相互作用的双相数学模型,该模型可区分靶点特异性抑制和非靶点抑制,并为多驱动因素的结肠癌细胞提出有效的靶向药物组合。
Cancers (Basel). 2020 Feb 13;12(2):436. doi: 10.3390/cancers12020436.
2
Asparaginase induces selective dose- and time-dependent cytotoxicity, apoptosis, and reduction of NFκB expression in oral cancer cells.门冬酰胺酶诱导口腔癌细胞选择性的剂量和时间依赖性细胞毒性、细胞凋亡和 NFκB 表达减少。
Clin Exp Pharmacol Physiol. 2020 May;47(5):857-866. doi: 10.1111/1440-1681.13256. Epub 2020 Jan 28.
3
使用数学建模来估计与时间无关的癌症化疗疗效参数。
In Silico Pharmacol. 2021 Dec 5;10(1):2. doi: 10.1007/s40203-021-00117-7. eCollection 2022.
Determinants of combination GM-CSF immunotherapy and oncolytic virotherapy success identified through in silico treatment personalization.
通过计算治疗个体化鉴定出组合 GM-CSF 免疫治疗和溶瘤病毒治疗成功的决定因素。
PLoS Comput Biol. 2019 Nov 27;15(11):e1007495. doi: 10.1371/journal.pcbi.1007495. eCollection 2019 Nov.
4
The emergence of drug resistance to targeted cancer therapies: Clinical evidence.耐药性的出现对靶向癌症治疗:临床证据。
Drug Resist Updat. 2019 Dec;47:100646. doi: 10.1016/j.drup.2019.100646. Epub 2019 Sep 26.
5
Mathematical modelling of cancer stem cell-targeted immunotherapy.癌症干细胞靶向免疫疗法的数学建模
Math Biosci. 2019 Dec;318:108269. doi: 10.1016/j.mbs.2019.108269. Epub 2019 Oct 14.
6
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm.通过新的个性化算法预测转移性黑色素瘤对 pembrolizumab 的反应。
J Transl Med. 2019 Oct 7;17(1):338. doi: 10.1186/s12967-019-2081-2.
7
Evaluation of IC levels immediately after treatment with anticancer reagents using a real-time cell monitoring device.使用实时细胞监测设备评估抗癌试剂治疗后即刻的IC水平。
Exp Ther Med. 2019 Oct;18(4):3197-3205. doi: 10.3892/etm.2019.7876. Epub 2019 Aug 13.
8
Targeting transcription factors in cancer - from undruggable to reality.靶向癌症转录因子——从不可成药到现实。
Nat Rev Cancer. 2019 Nov;19(11):611-624. doi: 10.1038/s41568-019-0196-7. Epub 2019 Sep 11.
9
Patient-specific parameter estimates of glioblastoma multiforme growth dynamics from a model with explicit birth and death rates.从具有明确出生率和死亡率的模型中估计胶质母细胞瘤多形性生长动力学的患者特异性参数。
Math Biosci Eng. 2019 Jun 11;16(5):5307-5323. doi: 10.3934/mbe.2019265.
10
Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy.雄激素剥夺治疗下前列腺癌模型的可预测性和可识别性评估。
Math Biosci Eng. 2019 Apr 19;16(5):3512-3536. doi: 10.3934/mbe.2019176.